IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
A Comparative Study of Functional Outcome in Patients with Early Osteoarthritis of Knee Treated with Platelet-Rich Plasma with Conventional Treatment

Author: M.K. KUMAR, M. NARAYANA REDDY
Abstract: Across the world, the most commonest adult joint disease is osteoarthritis OA. OA is a disease of synovial joint involving the whole joint organ affecting primarily the cartilage, bone and capsule. WHO estimates 40% of people over the age of 70 years agonize from OA knee. The average Indian life expectancy is approximately 69.6 years. Due to increased awareness about osteoarthritis (OA) people report with early symptoms in the orthopaedic clinics. Pharmacological therapy needs a long term usage and most of the patients have contraindications for long term usage of NSAIDs. In spite of great advances in the knee joint replacement surgery and improved biomechanics, the best available implant design cannot match the natural knee function and mechanics. The purpose of this paper is to analyse the efficiency of platelet amusing plasma in patients suffering from early osteoarthritis of knee and compare the functional outcomes of autologous platelet rich plasma with conventional treatment in patients diagnosed with initial osteoarthritis of knee.
Keyword: Osteoarthritis, WHO, Orthopaedic Aids, Orthosisand Pharmacotherapy.
DOI: https://doi.org/10.31838/ijpr/2019.11.04.108
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus